An investigation of strategies enhancing the public health role of community pharmacists: A review of knowledge and information

Journal of Pharmaceutical Health Services Research

Volumn 5, Issue 2, 2014, Pages 135-145

  Agomo, Chijioke O ^a,b   Ogunleye, James ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b MIDDLESEX UNIVERSITY   (United Kingdom)

Author keywords

Community pharmacists; Health policy; Health services research; Patient satisfaction; Public health role; Quality of care

Indexed keywords

ARTICLE; EDUCATION PROGRAM; EVIDENCE BASED PRACTICE; EXPERIENCE; HUMAN; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; MEDICAL STUDENT; PHARMACIST; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; PROFESSIONAL PRACTICE; PUBLIC HEALTH SERVICE; SELF CARE; SOCIAL MEDIA; UNITED KINGDOM;

EID: 84900464340     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/jphs.12056     Document Type: Article

References (83)

1. Department of Health. Healthy Lives, Healthy People: Our Strategy for Public Health in England. Norwich: Stationery Office, 2010.
2. Marmot M. Fair Society, Healthy Lives: Strategic Review of Health Inequalities in England post 2010. 2010; http://www.instituteofhealthequity.org/projects/fair-society-healthy-lives-the-marmot-review (accessed 24 November 2013).
3. Department of Health. A Vision for Adult Social Care: Capable Communities and Active Citizens. London: DoH, 2010.
4. Department of Health. Pharmacy in England: Building on Strengths - Delivering the Future. London: Stationery Office, 2008.
5. McGuire TR etal. Accessing rural populations: role of the community pharmacist in a breast and cervical cancer screening programme. J Eval Clin Pract 2007; 13: 146-149.
6. Anderson C. Health promotion by community pharmacists: perceptions, realities and constraints. Journal Soc Admin Pharm 1998; 15: 10-22.
7. Anderson C, Blenkinsopp A. Community pharmacy's contribution to improving public health: learning from local initiatives. Pharm J 2003; 271: 623-625.
8. Blenkinsopp A etal. Evaluation of feasibility and acceptability of a community pharmacy health promotion scheme - views of users and providers. Health Educ J 2002; 61: 52-69.
9. Agomo C. The role of community pharmacists in public health: a scoping review of the literature. J Pharm Health Serv Res 2012; 3: 25-33.
10. Department of Health. Equity and Excellence: Liberating the NHS. Norwich: Stationery Office, 2010.
11. Bjorkman I etal. Health promotion at Swedish pharmacies - views of the staff. Pharm Prac 2008; 6: 211-218.
12. Truong H, Patterson BY. Professional and educational initiatives, supports, and opportunities for advanced training in public health. Am J Pharm Educ 2010; 74: 122.
13. Trapskin K etal. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services. J Am Pharm Assoc (Wash DC) 2009; 49: 642-651.
14. McDaniel PA, Malone RE. Why California retailers stop selling tobacco products, and what their customers and employees think about it when they do: case studies. BMC Public Health 2011; 11: 848.
15. Johnson CL etal. Neighborhood geographical factors and the presence of advanced community pharmacy practice sites in Greater Chicago. Am J Pharm Educ 2009; 73: 1-6.
16. Eades CE etal. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health 2011; 11: 582.
17. Cain J etal. Pharmacy, social media, and health: opportunity for impact. J Am Pharm Assoc (Wash DC) 2010; 50: 745-751.
18. Lam B. Let's Skype Our Way to Better Health. 2013; http://www.pjonline.com/blog_entry/let%E2%80%99s_skype_our_way_to_better_health (accessed 24 November 2013).
19. Agomo C. Telemedicine: improving health services through technology. Pharm J 2008; 281: 103-105.
20. Agomo C. Is there a better way of using new technologies for patient benefit? Pharm J 2012; 288: 779.
21. News Team. PDA wants to see community pharmacies adopt two-pharmacist model. Pharm J 2011; 286: 258.
22. Wong MC etal. Factors associated with compliance to thiazide diuretics among 8551 Chinese patients. J Clin Pharm Ther 2011; 36: 179-186.
23. Trueman P etal. Evaluation of the Scale, Causes and Costs of Waste Medicines - Final Report. 2010; http://eprints.pharmacy.ac.uk/2605/1/Evaluation_of_NHS_Medicines_Waste__web_publication_version.pdf (accessed 24 November 2013).
24. Gavaza P etal. Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol 2011; 72: 143-152.
25. Brown-Benedict DJ. The Doctor of Nursing Practice degree: lessons from the history of the professional doctorate in other health disciplines. J Nurs Educ 2008; 47: 448-457.
26. Drexel University. DrPH Degree in Community Health and Prevention. 2013; http://publichealth.drexel.edu/academics/degrees/drph-degree-in-community-health/ (accessed 24 November 2013).
27. DiPietro NA etal. Public health content in didactic and experiential curricula of U.S. Doctor of Pharmacy programs. Intl J Pharm Educ Prac 2011; 7: 1-14.
28. Anderson S. Professional Doctorates in Public Health. 2012; http://www.pjonline.com/clinical-pharmacist/2012_jun/correspondence_public_health_doctorate (accessed 24 November 2013).
29. Paccaud F etal. Public health education in Europe: old and new challenges. Public Health Rev 2011; 33: 66-86.
30. Brown B etal. Service-learning elective to promote enhanced understanding of civic, cultural, and social issues and health disparities in pharmacy. Am J Pharm Educ 2007; 71: 1-7.
31. Schwartzberg JG etal. Communication techniques for patients with low health literacy: a survey of physicians, nurses, and pharmacists. Am J Health Behav 2007; 31(Suppl.): S96-S104.
32. Emmerton LM etal. Exploring health literacy competencies in community pharmacy. Health Expect 2010; 15: 12-22.
33. Rowlands G. Health literacy and public health: a framework for developing skills and empowering citizens. Perspect in Public Health 2012; 132: 23-24.
34. Roughead EE etal. Continuity of care: when do patients visit community healthcare providers after leaving hospital? Intern Med J 2011; 41: 662-667.
35. Sookaneknun P etal. Public opinion on establishing a university pharmacy as the health information center in its community. J Sci Technol, Mahasarakham University 2009; 28: 185-195.
36. Carter BL etal. The Iowa continuity of care study: background and methods. Am J Health Syst Pharm 2008; 65: 1631-1642.
37. News Team. Interprofessional working must be a priority, says MPs. Pharm J 2012; 289: 619.
38. Sampselle CM etal. The CTSA mandate: are we there yet? Res Theory Nurs Pract 2010; 24: 64-73.
39. Zerhouni E. NIH in the post-doubling era: realities and strategies. Science 2006; 314: 1088-1090.
40. Zerhouni E. The NIH roadmap. Science 2003; 302: 63-64, 72.
41. Baqir W etal. Cost analysis of a community pharmacy 'minor ailment scheme' across three primary care trusts in the North East of England. J Public Health (Bangkok) 2011; 33: 551-555.
42. Buabeng KO etal. Self-reported use of anti-malarial drugs and health facility management of malaria in Ghana. Malar J 2007; 6: 85.
43. Taylor D, Bury M. Chronic illness, expert patients and care transition. Sociol Health Ill 2007; 29: 27-45.
44. You JH etal. Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong. BMC Clin Pharmacol 2011; 11: 19.
45. Wong FYY etal. Patient self-management and pharmacist-led patient self-management in Hong Kong: a focus group study from different healthcare professionals' perspectives. BMC Health Serv Res 2011; 11: 121.
46. Agomo C. Is it time for a PharmD programme in the UK? Pharm J 2011; 286: 618.
47. Agomo C. Why pharmacists must teach students. Pharm J 2012; 288: 279.
48. Abrons J etal. Encouraging safe medication disposal through student pharmacist intervention. J Am Pharm Assoc (Wash DC) 2010; 50: 169-173.
49. Fradgley S, Smith J. Purple Waste - How a Hospital Trust deals with hazardous waste medicines. 2012; http://www.pjonline.com/news/purple_waste_%E2%80%94_how_a_hospital_trust_deals_with_hazardous_waste_medicines (accessed 24 November 2013).
50. Munger MA. Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus. Drugs Aging 2010; 27: 871-883.
51. NHS Scotland and The Scottish Government. Polypharmacy Guidance October 2012. 2012; www.central.knowledge.scot.nhs.uk/upload/Polypharmacy%20full%20guidance%20v2.pdf (accessed 24 November 2013).
52. Ambrose PJ. Educational opportunities and anti-doping roles and responsibilities for pharmacists. Yakugaku Zasshi 2011; 131: 1761-1764.
53. Lee SS etal. Pharmacists' and pharmacy students' ability to identify drug-related problems using TIMER (Tool to Improve Medications in the Elderly via Review). Am J Pharm Educ 2009; 73: 1-10.
54. Chaar BB. Provision of opioid substitution therapy services in Australian pharmacies. Australas Med J 2011; 4: 210-216.
55. Agomo C etal. An investigation of nicotine replacement therapy provision by community pharmacists in Wandsworth Primary Care Trust, London. Pharm J 2006; 277: 609-611.
56. Agomo C. Why partnerships may be a magic wand. Pharm J 2012; 288: 8.
57. The Scottish Government. Prescription for excellence: A Vision and Action Plan for the right Pharmaceutical Care through Integrated Partnerships and Innovation 2013; http://www.scotland.gov.uk/Resource/0043/00434053.pdf (accessed 24 November 2013).
58. Bush J etal. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom. Res Social Adm Pharm 2009; 5: 305-318.
59. Sinclair H, Lennox AS. Support from pharmacies can help people stop smoking. Br Med J 2001; 322: 52.
60. West R etal. Impact of UK policy initiatives on use of medicines to aid smoking cessation. Tob Control 2005; 14: 166-171.
61. Hudmon KS etal. Reducing pulmonary disease: the pharmacist's role in smoking cessation. J Pharm Pract 2001; 14: 143-159.
62. Kurko T etal. Community pharmacists' involvement in smoking cessation: familiarity and implementation of the national smoking cessation guideline in Finland. BMC Public Health 2010; 10: 444.
63. Agomo C. Why UK pharmacy must adapt to the increasing demands of professionalism in practice. Int J Pharm Practic 2012; 20: 320-323.
64. Wahba P, Steenhuysen J. CVS becomes first big U.S. drugstore chain to drop tobacco. 2014; http://www.reuters.com/article/2014/02/05/us-cvscaremark-cigarettes-idUSBREA140RP20140205 (accessed 05 February 2014).
65. Hogenboom M. Electronic cigarettes 'could save millions of lives' - BBC News Online. 2013; http://www.bbc.co.uk/news/health-24914473 (accessed 21 November 2013).
66. West R etal. Smoking cessation guidelines for health professionals: an update. Thorax 2000; 55: 987-999.
67. Patterson BY. An advanced pharmacy practice experience in public health. Am J Pharm Educ 2008; 72: 125.
68. Whitley HP. A public health discussion series in an advanced pharmacy practice experience. Am J Pharm Educ 2010; 74: 101.
69. Agomo C. Widening the UK pharmacy curriculum could help create jobs for pharmacists. Pharm J 2012; 289: 627.
70. Westrick SC etal. College/school of pharmacy affiliation and community pharmacies' involvement in public health activities. Am J Pharm Educ 2009; 73: Article 123.
71. Cerulli J, Malone M. Women's health promotion within a community advanced pharmacy practice experience. Am J Pharm Educ 2008; 72: 1-7.
72. Horsfield E etal. What do community pharmacists think about undertaking screening and brief interventions with problem drinkers? Results of a qualitative study in New Zealand and England. Int J Pharm Practic 2011; 19: 192-200.
73. Hind CA etal. Needs assessment study for community pharmacy travel medicine services. J Travel Med 2008; 15: 328-334.
74. Saramunee K etal. How to enhance public health service utilization in community pharmacy: general public and health providers' perspectives. 2012; http://www.sciencedirect.com/science/article/pii/S1551741112000745 (accessed 10 February 2014).
75. Watson MC, Blenkinsopp A. The feasibility of providing community pharmacy-based services for alcohol misuse: a literature review. Int J Pharm Pract 2009; 17: 199-205.
76. Dhital R. Feasibility and usefulness of setting up an alcohol screening service in community pharmacy. MSc dissertation, University College London, 2004.
77. Fitzgerald N, Stewart D. Drinking Interventions in Pharmacies Study (DIPS). 2006; http://alcoholresearchuk.org/downloads/finalReports/AERC_FinalReport_0038.pdf (accessed 27 October 2011).
78. Solutions for Public Health. Community Pharmacy and Public Health. 2013; http://www.sph.nhs.uk/sph-documents/community-pharmacy-and-public-health-final-report (accessed 04 February 2014).
79. Public Health England. Consolidating and Developing the Evidence Base and Research for Community Pharmacy's Contribution to Public Health: a Progress Report from Task Group 3 of the Pharmacy and Public Health Forum. London: PHE, 2014.
80. Anderson C etal. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002. Health Expect 2004; 7: 191-202.
81. Martin S etal. Do Quality Improvements in Primary Care Reduce Secondary Care Costs?: Primary Research Into the Impact of the QUALITY and Outcomes Framework on Hospital Costs and Mortality. 2010. www.health.org.uk/media_manager/public/75/QOFnew.pdf (accessed 15 February 2014).
82. Agomo C. Why improving the work-life balance of pharmacists might benefit employers and the profession. J Pharm Health Serv Res 2012; 3: 179-181.
83. Smith J etal. Now or Never: Shaping Pharmacy for the Future. London: Royal Pharmaceutical Society, 2013.